KB-03

N/A

Report date: 2025/06/11 11:04:01
NME

Base Information

Drug NameKB-03
Drug Alias NameCXCR1 antagonist (Kerberos Pharma)FX-68KB-03
ClassificationSmall molecules
Mechanisms of ActionMetastasis inhibitorsC-X3-C motif chemokine receptor 1 antagonists
TargetsC-X3-C motif chemokine receptor 1
Therapy Area/IndicationsInflammatory Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKerberos Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesKerberos Biopharma Inc
Inactive CompaniesN/A
Active IndicationsInflammatory Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A